SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000908662-08-000115
Filing Date
2008-04-01
Accepted
2008-04-01 16:40:39
Documents
1
Period of Report
2008-03-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3284
  Complete submission text file 0000908662-08-000115.txt   5239
Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GTC BIOTHERAPEUTICS INC (Issuer) CIK: 0000904973 (see all company filings)

IRS No.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0101
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address GTC BIOTHERAPEUTICS, INC. 175 CROSSING BOULEVARD FRAMINGHAM MA 01702
Business Address C/O GTC BIOTHERAPEUTICS, INC. 175 CROSSING BOULEVARD FRAMINGHAM MA 01702 5086209700
MCNAMARA PAMELA W (Reporting) CIK: 0001239717 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21794 | Film No.: 08729891